NCT07676396 Impact of Intracanal Cryotherapy and Corticosteroids on Post Endodontic Pain Status COMPLETED Phase PHASE4
NCT07674576 Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy Status NOT_YET_RECRUITING Phase PHASE3
NCT07672873 Local Dexamethasone Administration in Symptomatic Irreversible Pulpitis Status RECRUITING Phase NA
NCT07671066 Dexmedetomidine Versus Dexamethasone as an Additive to Local Anesthetic Mixture in Peribulbar Block in Cataract Surgeries Status COMPLETED Phase NA
NCT07665450 A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned Status NOT_YET_RECRUITING Phase PHASE3
NCT07663253 Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients Status RECRUITING Phase N/A
NCT07662200 A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07651150 DEX-HIP Trial: Preoperative IV Dexamethasone 4 mg vs Placebo to Reduce Postoperative Delirium Burden in Adults ≥70 Undergoing Hip Fracture Surgery Status COMPLETED Phase NA
NCT07649525 Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level Status RECRUITING Phase PHASE3
NCT07643103 Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT07637526 Study to Evaluate Efficacy and Safety of Belantamab-based Combinations for Relapsed Multiple Myeloma Status NOT_YET_RECRUITING Phase N/A
NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment Status NOT_YET_RECRUITING Phase PHASE2
NCT07624513 Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE3
NCT07615595 Dexamethasone to Prevent Side Effects of Spinal Anesthesia in Cesarean Delivery Status ENROLLING_BY_INVITATION Phase PHASE4
NCT07614360 Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE2
NCT07609706 A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment Status NOT_YET_RECRUITING Phase PHASE1
NCT07608731 Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas Status NOT_YET_RECRUITING Phase PHASE1
NCT07605416 Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial Status RECRUITING Phase PHASE2